Nuclear Imaging Equipment Market Size is USD 6.99 Billion in 2026

The global nuclear imaging equipment market is projected to grow from over USD 6.77 billion in 2024 to approximately USD 9.37 billion by 2035, reflecting a steady CAGR of 3.30%. This growth is driven by advancements in technology, increasing demand for early diagnosis, and expanding healthcare infrastructure globally.

Nuclear Imaging Equipment Market Statical Scope

Market Overview

The nuclear imaging equipment market is leveraging due to the transition in minimally invasive procedures. Nuclear imaging equipment holds the detection power of discarded radiation from radiopharmaceuticals captured in a patient’s body. The market is well engineered to navigate metabolic and physiological movements directly through its inside-out imaging. The initial SPECT, PET, and Gamma Camera, alongside the image blender and supporting instruments, are the heart of the market.

Regional Insights

• North America: Healthcare acquisitions and giants' involvement lead to regional advancement. Whereas, automated image reconstruction and hybrid modalities are bolstered to stimulate the regional market growth.
• Europe: The oncology sector, hybrid systems, AI integration, and a transitional move for the hybrid imaging modalities are accelerating the regional market growth.
• Asia Pacific: The rising prevalence of neurological disorders, cardiovascular conditions, and cancer is accelerating the demand for precision diagnostic tools for precision treatment.
• Latin America: The public-private collaborations and market players’ commendable innovation and investment from Brazil and Mexico are fuelling the market growth.
• Middle East & Africa: Artificial Intelligence, refurbished equipment, and technological shifts are driving the regional market growth.

Nuclear Imaging Equipment Market Share, By Region, 2025 (%)

• North America (35%) — Largest regional market, driven by high healthcare expenditure, advanced medical infrastructure, and early adoption of nuclear imaging technologies.
• Europe (25%) — Mature market with established healthcare systems and widespread use of nuclear imaging for clinical diagnostics.
• Asia Pacific (30%) — Rapidly growing market due to increased healthcare investments, rising disease prevalence, and expanding access to medical technologies.
• LAMEA (10%) — Smaller market with lower penetration of advanced nuclear imaging equipment, but gradually expanding due to healthcare improvements in select regions.

Segmental Insights

By Modality

• SPECT: SPECT segment delivers an expertise-level tomographic modality, giving an overview of how the organ actually works. SPECT is operative in hybrid imaging, physiological, and functional evaluation.
• PET: PET segment evaluates the organ functions, monitors treatments, and acts as a guide to violent tumor space for precise targeted treatment and biopsies.

Nuclear Imaging Equipment Market Share, By Modality, 2025 (%)

• SPET (45%) — Single-photon emission tomography (SPET) uses gamma rays to produce 3D images of internal body structures, often used in cardiac and neurological imaging.
• PET (55%) — Positron emission tomography (PET) produces high-resolution images of the body's metabolic processes, commonly used for oncology and cardiology applications.

By Application

• Cardiology: The segment stimulates as nuclear imaging equipment uses a radioactive navigator to have a realistic view of blood flow, molecular movement, and heart function in cardiology.
• Oncology: The segment involves both SPECT/CT and PET/CT scanners, as well as radioactive tracers to allow the detection of cancer, accurate staging, and smart/genuine monitoring, promoting functional imaging.

Nuclear Imaging Equipment Market Share, By Application, 2025 (%)

• Cardiology (25%) — Nuclear imaging techniques used for diagnosing and monitoring heart conditions, such as coronary artery disease and myocardial infarctions.
• Oncology (40%) — Nuclear imaging techniques utilized for detecting and staging various cancers, including tumor localization and metastasis tracking.
• Neurology (20%) — Nuclear imaging applications in the brain, used for diagnosing neurological disorders like Alzheimer's, Parkinson's, and epilepsy.
• Others (15%) — Nuclear imaging techniques used for other medical conditions, including infections, inflammation, and bone disorders.

By End-use

• Hospitals: The hospitals segment handles crucial modern technologies and contributes to the clinical application, maintenance, and procedures of nuclear imaging equipment.
• Imaging Centers: The Imaging Centers segment in the market operates manage and obtains modern equipment to spot abnormal activities in the neurology, oncology, and cardiology fields.

Nuclear Imaging Equipment Market Companies

• GE HealthCare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Mediso
• Cubresa Inc.
• Shimadzu Corporation
• United Imaging Healthcare Co

Nuclear Imaging Equipment Market Segmentation

By Modality

• SPET
  PET

By Application

• Cardiology
• Oncology
• Neurology
• Others

By End Use

• Hospitals
• Imaging Centers
• R&D
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa